IBDEI1NL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29378,2)
 ;;=^275214
 ;;^UTILITY(U,$J,358.3,29379,0)
 ;;=907.0^^175^1880^3
 ;;^UTILITY(U,$J,358.3,29379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29379,1,3,0)
 ;;=3^Late Effect w/o Skull Fx
 ;;^UTILITY(U,$J,358.3,29379,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,29379,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,29380,0)
 ;;=V15.52^^175^1880^1
 ;;^UTILITY(U,$J,358.3,29380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29380,1,3,0)
 ;;=3^Personal Hx of TBI
 ;;^UTILITY(U,$J,358.3,29380,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,29380,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,29381,0)
 ;;=V15.59^^175^1881^1
 ;;^UTILITY(U,$J,358.3,29381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29381,1,3,0)
 ;;=3^Personal Hx of Injury
 ;;^UTILITY(U,$J,358.3,29381,1,4,0)
 ;;=4^V15.59
 ;;^UTILITY(U,$J,358.3,29381,2)
 ;;=^336787
 ;;^UTILITY(U,$J,358.3,29382,0)
 ;;=413.9^^175^1882^1
 ;;^UTILITY(U,$J,358.3,29382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29382,1,3,0)
 ;;=3^Angina Pectoris NEC/NOS
 ;;^UTILITY(U,$J,358.3,29382,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,29382,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,29383,0)
 ;;=716.90^^175^1882^2
 ;;^UTILITY(U,$J,358.3,29383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29383,1,3,0)
 ;;=3^Arthropathy NOS
 ;;^UTILITY(U,$J,358.3,29383,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,29383,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,29384,0)
 ;;=428.0^^175^1882^3
 ;;^UTILITY(U,$J,358.3,29384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29384,1,3,0)
 ;;=3^CHF,Unspec
 ;;^UTILITY(U,$J,358.3,29384,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,29384,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,29385,0)
 ;;=585.9^^175^1882^4
 ;;^UTILITY(U,$J,358.3,29385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29385,1,3,0)
 ;;=3^Chr Kidney Disease NOS
 ;;^UTILITY(U,$J,358.3,29385,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,29385,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,29386,0)
 ;;=585.1^^175^1882^5
 ;;^UTILITY(U,$J,358.3,29386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29386,1,3,0)
 ;;=3^Chr Kidney Disease,Stage I
 ;;^UTILITY(U,$J,358.3,29386,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,29386,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,29387,0)
 ;;=585.2^^175^1882^6
 ;;^UTILITY(U,$J,358.3,29387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29387,1,3,0)
 ;;=3^Chr Kidney Disease,Stage II
 ;;^UTILITY(U,$J,358.3,29387,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,29387,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,29388,0)
 ;;=585.3^^175^1882^7
 ;;^UTILITY(U,$J,358.3,29388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29388,1,3,0)
 ;;=3^Chr Kidney Disease,Stage III
 ;;^UTILITY(U,$J,358.3,29388,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,29388,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,29389,0)
 ;;=585.4^^175^1882^8
 ;;^UTILITY(U,$J,358.3,29389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29389,1,3,0)
 ;;=3^Chr Kidney Disease,Stage IV
 ;;^UTILITY(U,$J,358.3,29389,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,29389,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,29390,0)
 ;;=585.5^^175^1882^9
 ;;^UTILITY(U,$J,358.3,29390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29390,1,3,0)
 ;;=3^Chr Kidney Disease,Stage V
 ;;^UTILITY(U,$J,358.3,29390,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,29390,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,29391,0)
 ;;=585.6^^175^1882^11
 ;;^UTILITY(U,$J,358.3,29391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29391,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,29391,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,29391,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,29392,0)
 ;;=401.9^^175^1882^12
 ;;^UTILITY(U,$J,358.3,29392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29392,1,3,0)
 ;;=3^Hypertension
 ;;
 ;;$END ROU IBDEI1NL
